Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clozapine treatment of schizophrenic patients.

Trial Profile

Clozapine treatment of schizophrenic patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs Risperidone (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2012 Additional lead trial center identified as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Additional lead investigator identified as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Primary endpoint identified as Brief Psychiatric Rating Scale as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top